Alembic Pharmaceuticals Limited (APLLTD) secures USFDA final approval for Venetoclax Tablets, 10 mg, 50 mg, and 100 mg, expanding its generic drug portfolio.
Artemis Medicare Services Limited (ARTEMISMED) reports a 13.2% YoY revenue increase and a 22.7% rise in adjusted EBITDA for Q2 FY27.
Advait Energy Transitions Limited (NSE: ADVAIT) reports an impressive 88.5% growth in profit for Q2 FY27, with a significant boost in revenue and EBITDA.
Lodha Developers Limited (NSE: LODHA) delivers bumper profits in H1 FY27, expects to beat full-year guidance with strong revenue and profit growth.
Crizac Limited (CRIZAC) reports Q2 FY27 results with a 34.5% YoY decline in total income, but declares ₹4 interim dividend.
Ind-Swift Laboratories Limited (INDSWFTLAB) reports a 50% revenue increase and a 5.2x surge in Op. EBITDA for Q2 FY27.
Syrma SGS Technology Limited (SYRMA) reports Q2 FY27 results with ₹19,995 Mn revenue, ₹2,031 Mn EBITDA, and ₹1,242 Mn PAT.
Dhanuka Agritech Limited (DHANUKA) reports a 16.23% surge in Q2 FY27 net profit to ₹109.22 crore, with revenue growing 9.91% to ₹657.51 crore.
Lyka Labs Limited (LYKALABS) reports a 34% revenue surge and a 136% net profit increase in Q2FY27.
Pudumjee Paper Products Limited (PDMJEPAPER) reports a 21% increase in EBITDA to Rs.90 crores for Q2 FY26, driven by higher sales and capex benefits.
